Inmune Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.05

-0.05 (-4.55%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +1,506.7% upside

Low Target $11.09

Average Target $16.87

High Target $25.84

Current Price $1.05

Current
$1.05

Target
$16.87

$11.09 $16.87 avg $25.84

Scenario Analysis

Bear Case

$11.09

956.2%

Low target

Base Case

$16.87

+1,506.7%

Avg target

Bull Case

$25.84

+2,361.0%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$2.60

-59.6% from high

52-Week Low

$1.09

+-3.7% from low

Target vs 52W High

$16.87

+548.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.5%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.2%
MRNA Moderna Inc	Hold	31	32%	$149.45	-35.4%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.9%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.7%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-35.3%